Henagliflozin enhances frontal neural activation and cognitive function versus gliclazide in type 2 diabetes patients with mild cognitive impairment: A 16-week randomized controlled trial

Journal of Endocrinological Investigation 2026

View at publisher

Authors: Yining Chao, Jingyi Jiao, Bing Zhang, Jing Sun, Xuewei Tong, Huijie Yang, Tianyu Wu, Zhou Zhang, Yan Bi

DOI: 10.1007/s40618-025-02775-2

Cited by: 0

Fields of Study & Subjects

Dementia and Cognitive Impairment Research Diabetes Treatment and Management Cancer-related cognitive impairment studies